GEMZAR vs INLEXZO
Independent side-by-side comparison.
Rating
New
New
Pharmacy pays
~$599.88 /30
~$599.88 /30
Type
RX
RX
Active ingredient
GEMCITABINE HYDROCHLORIDE
GEMCITABINE HYDROCHLORIDE
Manufacturer
Dosage forms
Injectable
System
Drug class
Nucleoside Metabolic Inhibitor
Nucleoside Metabolic Inhibitor
Boxed warning
None
None
Treats
Breast Neoplasms, Non-Small-Cell Lung Carcinoma, Ovarian Neoplasms
Breast Neoplasms, Non-Small-Cell Lung Carcinoma, Ovarian Neoplasms
Frequently asked questions
Which is cheaper, Gemzar or Inlexzo?
Pharmacies pay about the same to acquire either one — roughly $599.88 for a 30-count supply, per the CMS NADAC survey. That is not what you will be charged: your price is set by your insurer and the pharmacy, not by what the drug cost them.
What is the difference between Gemzar and Inlexzo?
Both Gemzar and Inlexzo share the active ingredient Gemcitabine Hydrochloride.
Ratings are based on FDA regulatory (recall-safety) data. This comparison is for general reference only — not medical advice. Always consult a licensed professional before choosing or switching a medication.